Characteristics | n | % | 95% CI |
Age (years) (Average: 25.39 ± 6.24) | |||
£18 | 170 | 13.62 | 11.79 - 15.68 |
19 - 34 | 950 | 76.12 | 73.64 - 78.44 |
³35 | 128 | 10.26 | 8.66 - 12.11 |
Gravidity N = 1248 | |||
Primigravida | 304 | 24.36 | 22.06 - 26.82 |
Multigravida | 944 | 75.64 | 73.18 - 77.94 |
VIH serology N = 1248 | |||
Negative | 1206 | 96.63 | 95.48 - 97.50 |
Positive | 42 | 3.37 | 2.50 - 4.52 |
Use of IPTp-sp N = 1248 | |||
No | 59 | 4.73 | 3.68 - 6.05 |
Yes | 1189 | 95.27 | 93.95 - 96.32 |
Number of IPTp-sp doses N = 1248 | |||
0 - 2 | 299 | 23.96 | 21.67 - 26.40 |
3 - 4 | 949 | 76.04 | 73.60 - 78.33 |
ITNs N = 1248 | |||
No | 62 | 4.97 | 3.89 - 6.32 |
Yes | 1186 | 95.03 | 93.68 - 96.11 |
Arterial hypertension during current pregnancy N = 1248 | |||
No | 1200 | 96.15 | 94.94 - 97.09 |
Yes | 48 | 3.85 | 2.91 - 5.06 |
Malaria access during pregnancy N = 1248 | |||
Negative | 950 | 76.12 | 73.68 - 78.40 |
Positive | 298 | 23.88 | 21.60 - 26.32 |
Peripheral parasitaemia at delivery N = 1248 | |||
Negative | 1058 | 84.78 | 82.68 - 86.66 |
Positive | 190 | 15.22 | 13.34 - 17.32 |
Placental malaria p N =1248 | |||
Negative | 1062 | 85.10 | 83.01 - 86.96 |
Positive | 186 | 14.90 | 13.04 - 16.99 |
Maternal Hb at delivery (gr/dl) N = 1248 | |||
≥11 | 838 | 67.15 | 64.49 - 69.70 |
<11 | 410 | 32.85 | 30.30 - 35.51 |
Birth weight of newborn (gr) N = 1248 | |||
≥2500 | 1080 | 86.54 | 84.53 - 88.32 |
<2500 | 168 | 13.46 | 11.68 - 15.47 |